Rearranged T-cell receptor gene and positive Epstein-Barr virus-encoded nuclear RNA in an extranodal NK/T-cell lymphoma with cutaneous manifestation only: Case study

Clinical and Experimental Dermatology

Volumn 32, Issue 6, 2007, Pages 744-748

  Wang, J ^a   Geng, S A ^b   Su, Z ^c   Xu, J ^a   Xu, S ^a   Wang, F ^b   Mo, X ^c   Feng, Z ^c  

^a the Fourth Hospital   (China)

^b Department of Dermatology   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BETA CAROTENE; CD30 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CEFOTAXIME; CYCLOPHOSPHAMIDE; NUCLEAR RNA; PEPTIDE; PREDNISOLONE; PREDNISONE; THYMIC PEPTIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BLISTER; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DERMADROME; EPSTEIN BARR VIRUS; ERYTHEMA; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LABORATORY TEST; MALE; NASAL BIOPSY; NATURAL KILLER T CELL; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN INFLAMMATION; SKIN NECROSIS; T CELL LYMPHOMA; T CELL RECEPTOR GAMMA 2 GENE; T LYMPHOCYTE RECEPTOR GENE; ULTRASOUND; X RAY;

CHILD; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; SKIN NEOPLASMS;

EID: 35348980757     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02465.x     Document Type: Article

References (10)

1. Radonich MA, Lazova R, Bolognia J. Cutaneous natural killer/T-cell lymphoma. J Am Acad Dermatol 2002 46 : 451 6.
2. Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 2003 40 : 175 84.
3. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 85.
4. Cheung MM, Chan JK, Lau WH et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998 16 : 70 7.
5. Mraz-Gernhard S, Natkunam Y, Hoppe RT et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001 19 : 2179 88.
6. Chang SE, Yoon GS, Huh J et al. Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas. Appl Immunohistochem Mol Morph 2002 10 : 163 70.
7. Loughrey M, Trivett M, Lade S et al. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation. Pathology 2004 36 : 301 8.
8. Chattopadhyay A, Slater DN, Hancock BW. Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomas. Int J Oncol 2005 26 : 1559 62.
9. Hwang DK, Kwon HM, Park JW et al. TCR gene-rearranged, extranodal NK/T-cell lymphoma, nasal type, presenting as gyrate patches. J Dermatol 2002 29 : 648 52.
10. Bekkenk MW, Jansen PM, Meijer CJ et al. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004 15 : 1097 108.